Your browser doesn't support javascript.
loading
Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome.
Du, Peng; Geng, Jie; Wang, Feng; Chen, Xiaobo; Huang, Zhiwei; Wang, Yuliang.
Afiliação
  • Du P; Clinical Laboratory of Emergency Medicine, Tianjin Union Medical Centre, Tianjin, China.
  • Geng J; Graduate School of Tianjin Medical University, Tianjin, China.
  • Wang F; Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
  • Chen X; Unicell Life Science Development Co., Ltd, Tianjin, China.
  • Huang Z; Graduate School of Tianjin Medical University, Tianjin, China.
  • Wang Y; Department of Clinical Laboratory Medicine, the Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, China.
Int J Med Sci ; 18(6): 1356-1362, 2021.
Article em En | MEDLINE | ID: mdl-33628091
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-6 / Síndrome da Liberação de Citocina / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-6 / Síndrome da Liberação de Citocina / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article